Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy

References

• GerberDETargeted therapies: a new generation of cancer treatmentsAm Fam Physician200877331131918297955
   PubMed Web of Science ®Google Scholar
• GriffinAMButowPNCoatesASOn the receiving end V: patient perceptions of the side effects of cancer chemotherapy in 1993Ann Oncol1996721891958777177
   PubMedGoogle Scholar
• MullerIJennerABrucheltGNiethammerDHalliwellBEffect of concentration on the cytotoxic mechanism of doxorubicin-apoptosis and oxidative DNA damageBiochem Biophys Res Commun199723022542579016760
   PubMedGoogle Scholar
• BuzdarAUMarcusCSmithTLBlumenscheinGREarly and delayed clinical cardiotoxicity of doxorubicinCancer19855512276127653922612
   PubMed Web of Science ®Google Scholar
• ArapWPasqualiniRRuoslahtiECancer treatment by targeted drug delivery to tumor vasculature in a mouse modelScience199827953493773809430587
   PubMed Web of Science ®Google Scholar
• BarefordLMSwaanPWEndocytic mechanisms for targeted drug deliveryAdv Drug Deliv Rev200759874875817659804
   PubMed Web of Science ®Google Scholar
• WeaverMLaskeDWTransferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomasJ Neurooncol200365131314649881
   PubMed Web of Science ®Google Scholar
• Kukowska-LatalloJFCandidoKACaoZNanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancerCancer Res200565125317532415958579
   PubMed Web of Science ®Google Scholar
• CalzolariAOlivieroIDeaglioSTransferrin receptor 2 is frequently expressed in human cancer cell linesBlood Cell Mol Dis20073918291
   PubMed Web of Science ®Google Scholar
• KawabataHYangRHiramaTMolecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like familyJ Biol Chem199927430208262083210409623
   PubMed Web of Science ®Google Scholar
• QianZMLiHSunHHoKTargeted drug delivery via the transferrin receptor-mediated endocytosis pathwayPharmacol Rev200254456158712429868
   PubMed Web of Science ®Google Scholar
• DanielsTRDelgadoTHelgueraGPenichetMLThe transferrin receptor part II: targeted delivery of therapeutic agents into cancer cellsClin Immunol2006121215917616920030
   PubMed Web of Science ®Google Scholar
• DixitSNovakTMillerKZhuYKenneyMEBroomeAMTransferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumorsNanoscale2015751782179025519743
   PubMed Web of Science ®Google Scholar
• LiJLWangLLiuXYIn vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticlesCancer Lett2009274231932618977071
   PubMed Web of Science ®Google Scholar
• WangFWangYCDouSXiongMHSunTMWangJDoxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cellsACS Nano2011553679369221462992
   PubMed Web of Science ®Google Scholar
• WijayaASchafferSBPallaresIGHamad-SchifferliKSelective release of multiple DNA oligonucleotides from gold nanorodsACS Nano200931808619206252
   PubMed Web of Science ®Google Scholar
• SalemAKSearsonPCLeongKWMultifunctional nanorods for gene deliveryNat Mater200321066867112970757
   PubMed Web of Science ®Google Scholar
• HuangHCBaruaSKayDBRegeKSimultaneous enhancement of photothermal stability and gene delivery efficacy of gold nanorods using polyelectrolytesACS Nano20093102941295219856978
   PubMedGoogle Scholar
• ChandaNShuklaRKattiKVKannanRGastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nanovectors for molecular imagingNano Lett2009951798180519351145
   PubMed Web of Science ®Google Scholar
• HuschkaRZuloagaJKnightMWBrownLVNordlanderPHalasNJLight-induced release of DNA from gold nanoparticles: nanoshells and nanorodsJ Am Chem Soc201113331122471225521736347
   PubMed Web of Science ®Google Scholar
• SunZNiWYangZKouXLiLWangJpH-controlled reversible assembly and disassembly of gold nanorodsSmall2008491287129218686276
   PubMedGoogle Scholar
• RameshRItoIGopalanBSaitoYMhashilkarAMChadaSEctopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cellsMol Ther20049451051815093181
   PubMedGoogle Scholar
• InoueSHartmanABranchCDmda-7 in combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograftMol Ther200715228729417235306
   PubMed Web of Science ®Google Scholar
• PanneerselvamJShankerMJinJPhosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activityOncotarget2015618162711628626009991
   PubMedGoogle Scholar
• PanneerselvamJJinJShankerMIL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 Signaling AxisPLoS One2015103e012243925775124
   PubMedGoogle Scholar
• KurodaSTamJRothJASokolovKRameshREGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damageInt J Nanomedicine201493825383925143731
   PubMed Web of Science ®Google Scholar
• TanakaTMunshiABrooksCLiuJHobbsMLMeynREGefitinib radiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacityClin Cancer Res20081441266127318281562
   PubMed Web of Science ®Google Scholar
• CugiaFMonduzziMNinhambBWSalisAInterplay of ion specificity, pH and buffers: insights from electrophoretic mobility and pH measurements of lysozyme solutionsRSC Adv201331758825888
   Google Scholar
• El-KarehAWSecombTWTwo-mechanism peak concentration model for cellular pharmacodynamics of doxorubicinNeoplasia20057770571316026650
   PubMed Web of Science ®Google Scholar
• SchaferKBraunHAIsenbergCEffect of menthol on cold receptor activity. Analysis of receptor processesJ Gen Physiol19868867577763794639
   PubMedGoogle Scholar
• MooreAJosephsonLBhoradeRMBasilionJPWeisslederRHuman transferrin receptor gene as a marker gene for MR imagingRadiology2001221124425011568347
   PubMedGoogle Scholar
• LebroJABennettMJVaughnDECrystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptorCell19989311111239546397
   PubMedGoogle Scholar
• MattiaERaoKShapiroDSSussmanHHKlausnerRDBiosynthetic regulation of the human transferrin receptor by desferrioxamine in K562 cellsJ Biol Chem19842595268926926142046
   PubMedGoogle Scholar
• CasaresNPequignotMOTesniereACaspase-dependent immunogenicity of doxorubicin-induced tumor cell deathJ Exp Med2005202121691170116365148
   PubMed Web of Science ®Google Scholar
• MaejimaYAdachiSItoHHiraoKIsobeMInduction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damageAging Cell20087212513618031568
   PubMedGoogle Scholar
• WangIKLin-ShiauSYLinJKInduction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of Caspase-9 and Caspase-3 in Leukaemia HL-60 CellsEur J Cancer199935101517152510673981
   PubMed Web of Science ®Google Scholar
• SoleimaniRHeytensEDarzynkiewiczZOktayKMechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromiseAging (Albany NY)20113878279321869459
   PubMedGoogle Scholar
• SedelnikovaOAWilliamMBGammaH2AX in cancer cells: a potential biomarker for cancer diagnostics, prediction and recurrenceCell Cycle20065242909291317172873
   PubMed Web of Science ®Google Scholar
• OlivePLBanáthJPThe comet assay: a method to measure DNA damage in individual cellsNat Protoc200611232917406208
   PubMed Web of Science ®Google Scholar
• DuanXXiaoJYinQSmart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiramACS Nano2013775858586923734880
   PubMed Web of Science ®Google Scholar
• WangLMaWMarkovichRChenJWWangPHRegulation of cardiomyocyte apoptotic signaling by insulin-like growth factor ICirc Res19988355165229734474
   PubMedGoogle Scholar
• SawyerDBFukazawaRArstallMAKellyRADaunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxaneCirc Res199984325726510024299
   PubMed Web of Science ®Google Scholar